AU3045389A - Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence - Google Patents

Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence

Info

Publication number
AU3045389A
AU3045389A AU30453/89A AU3045389A AU3045389A AU 3045389 A AU3045389 A AU 3045389A AU 30453/89 A AU30453/89 A AU 30453/89A AU 3045389 A AU3045389 A AU 3045389A AU 3045389 A AU3045389 A AU 3045389A
Authority
AU
Australia
Prior art keywords
rotavirus
involving
protein
optionally
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU30453/89A
Other versions
AU626288B2 (en
Inventor
Gerald Wayne Both
Sally Clare Stirzaker
Peter Lawrence Whitfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of AU3045389A publication Critical patent/AU3045389A/en
Application granted granted Critical
Publication of AU626288B2 publication Critical patent/AU626288B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU30453/89A 1988-02-05 1989-02-03 Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence Ceased AU626288B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI661288 1988-02-05
AUPI6612 1988-02-05

Publications (2)

Publication Number Publication Date
AU3045389A true AU3045389A (en) 1989-08-25
AU626288B2 AU626288B2 (en) 1992-07-30

Family

ID=3772783

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30453/89A Ceased AU626288B2 (en) 1988-02-05 1989-02-03 Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence

Country Status (3)

Country Link
EP (1) EP0398944A4 (en)
AU (1) AU626288B2 (en)
WO (1) WO1989007140A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU649950B2 (en) * 1989-04-27 1994-06-09 University Technologies International Inc. A method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0509841A3 (en) * 1991-04-18 1993-08-18 Tonen Corporation Co-expression system of protein disulfide isomerase gene and useful polypeptide gene and process for producing the polypeptide using its system
SE9101433D0 (en) * 1991-05-13 1991-05-13 Marianne Hansson RECOMBINANT DNA SEQUENCE AND ITS USE
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
EP1293571A3 (en) * 1992-07-08 2004-02-18 Unilever N.V. Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein
DK0673427T3 (en) * 1992-07-08 2003-07-21 Unilever Nv Enzymatic process using enzymes immobilized on the cell wall of a eukaryotic microbial cell to produce a fusion protein
EP1170368B1 (en) * 1994-01-27 2010-07-28 University Of Massachusetts Medical Center Immunization by inoculation of dna transcription unit
WO1997027216A1 (en) * 1996-01-29 1997-07-31 Georgetown University Amplification of response from expressed recombinant protein
WO1998024912A2 (en) * 1996-12-04 1998-06-11 Heska Corporation Recombinant plague vaccine
US6686168B1 (en) 1999-11-04 2004-02-03 Zymogenetics, Inc. Cell surface display of proteins by recombinant host cells
AU1455501A (en) * 1999-11-04 2001-05-14 Zymogenetics Inc. Cell surface display of proteins by recombinant host cells
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
EP1831375B1 (en) 2004-12-23 2014-07-16 Novozymes Biopharma DK A/S Gene expression technique
WO2010017209A2 (en) 2008-08-04 2010-02-11 The Government Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK582381A (en) * 1981-01-02 1982-07-03 Univ New York BRAKE COMBINATE PLASMID FOR USE IN BACTERIAL CLONING
AU5736286A (en) * 1985-05-14 1986-11-20 Commonwealth Scientific And Industrial Research Organisation Rotavirus antigens
IL79880A0 (en) * 1985-08-29 1986-11-30 Inst Medical W & E Hall Recombinant virus
US4935352A (en) * 1985-10-21 1990-06-19 Takeda Chemical Industries, Ltd. Expression vector for animal cell line and use thereof
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
EP0251467A3 (en) * 1986-06-20 1988-07-20 Abbott Laboratories Compositions and methods of use for a major outer capsid protein (vp7) of rotavirus sa-11
GB0426220D0 (en) * 2004-11-30 2004-12-29 Cadbury Schweppes Plc Apparatus and method for extruding a product

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU649950B2 (en) * 1989-04-27 1994-06-09 University Technologies International Inc. A method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same

Also Published As

Publication number Publication date
AU626288B2 (en) 1992-07-30
WO1989007140A1 (en) 1989-08-10
EP0398944A4 (en) 1991-09-11
EP0398944A1 (en) 1990-11-28

Similar Documents

Publication Publication Date Title
AU3045389A (en) Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence
AU688210B2 (en) Recombinant obese (Ob) proteins
AU3664597A (en) A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function
AU7593096A (en) Igg separation medium and novel protein a variant
EP0410323A3 (en) Immobilization of proteins and peptides on insoluble supports
HUP9800901A3 (en) Process, medium and cell culture system for the preparation of recombinant factor viii in a protein free medium
AU4761493A (en) Peptides containing respective amino acid sequences selected from among those of lipoprotein(a) and apolipoprotein(a), antibodies respectively recognizing these amino acid sequences, and method of assaying with these antibodies
AU4215389A (en) An apparatus and a method for the synthesis of peptides
AU7679196A (en) System and method for a multi-host subscriber loop
AU4413096A (en) Phenylalanine free proteins
AU6428890A (en) Therapeutic peptides and proteins
AU4754490A (en) Heat-labile toxin b subunit fusion proteins
AU5109796A (en) Export systems for recombinant proteins
AU4635593A (en) Vesicle membrane transport proteins
AU5635896A (en) Recombinant endotoxin-neutralizing proteins
AU4508689A (en) Recombinant pdgf and methods for production
AU4157489A (en) Buffer storage system
AU4927390A (en) Fusion proteins
AU6390496A (en) Depigmenting activity of agouti signal protein and peptides thereof
AU1841788A (en) Immunosuppressant peptides
AU3193089A (en) Prepromotilin and motilin-associated peptide (map)
AU2497095A (en) Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
EP0855029A4 (en) A high throughput assay using fusion proteins
AU3804689A (en) Modified proteins
AU5878590A (en) New technique for rapid peptide coupling